Array BioPharma (ARRY) PT Raised to $19 at Jefferies
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.17 -0.39%
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
Jefferies analyst Eun Yang raised the price target on Array BioPharma (NASDAQ: ARRY) to $19.00 (from $18.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Stellantis NV (STLA:IM) (STLA) PT Lowered to EUR5 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
